scispace - formally typeset
F

Francesco E. Pontieri

Researcher at Sapienza University of Rome

Publications -  140
Citations -  8326

Francesco E. Pontieri is an academic researcher from Sapienza University of Rome. The author has contributed to research in topics: Parkinson's disease & Dopaminergic. The author has an hindex of 35, co-authored 128 publications receiving 7542 citations. Previous affiliations of Francesco E. Pontieri include National Institutes of Health & University of Cagliari.

Papers
More filters
Journal ArticleDOI

Which patients discontinue? Issues on Levodopa/carbidopa intestinal gel treatment: Italian multicentre survey of 905 patients with long-term follow-up

Mariachiara Sensi, +66 more
TL;DR: The high percentage of patients remaining on treatment in the short- and long-term follow-up confirms effectiveness of treatment, careful follow- up, and appropriate patient and caregivers training.
Journal ArticleDOI

Minocycline in amyotrophic lateral sclerosis: a pilot study.

TL;DR: This pilot study shows that minocycline and riluzole can be taken safely together, and further trials are needed to assess efficacy of such treatment.
Journal ArticleDOI

Adrenal dysregulation in amyotrophic lateral sclerosis.

TL;DR: The results showed the loss of circadian rhythm of cortisol levels in ALS, and levels of cortisol in the evening sample were significantly increased in ALS patients with respect to controls, indicating the dysregulation of adrenal activity in the disease.
Journal ArticleDOI

Amantadine in parkinsonian patients unresponsive to levodopa: a pilot study.

TL;DR: The creatine phosphate level in the opponens pollicis muscle after unilateral lesion of the median nerve was determined for the operated and contralateral hand muscle.
Journal ArticleDOI

Dopamine receptor mrnas in the rat lymphocytes

TL;DR: RT-PCR results provide further evidence for the interaction of dopamine systems and the immune system, and suggest the suitability of this animal species to further investigate the correlation between changes in the expression of central and peripheral dopamine receptors produced by manipulations of the dopamine systems.